2026-01-02 - Analysis Report
Okay, here's a breakdown of RTX Corp based on the provided data, aiming for clarity and simplicity:

**1) Return Rate Analysis**

*   **RTX Corp Overview:** RTX Corp is a global aerospace and defense company.
*   **RTX Cumulative Return:** 36.17%
*   **S&P 500 (VOO) Cumulative Return:** 105.07%
*   **Divergence:** -68.9 (Relative Divergence: 14.2)

**Analysis:** RTX has significantly underperformed the S&P 500 over the measured period. The divergence of -68.9 indicates a substantial difference in cumulative returns. The relative divergence of 14.2 suggests that the current divergence is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year      | CAGR   | MDD    | Alpha   | Beta  | Cap(B) |
|-----------|--------|--------|---------|-------|--------|
| 2016-2018 | 21.0%  | 72.6%  | -8.0%   | 0.9   | 89.8   |
| 2017-2019 | 37.0%  | 72.8%  | -5.0%   | 1.0   | 126.4  |
| 2018-2020 | -18.0% | 81.5%  | -50.0%  | 1.2   | 95.9   |
| 2019-2021 | 16.0%  | 81.5%  | -60.0%  | 1.2   | 115.4  |
| 2020-2022 | 7.0%   | 81.5%  | -12.0%  | 1.0   | 135.3  |
| 2021-2023 | 26.0%  | 79.0%  | -2.0%   | 0.7   | 112.8  |
| 2022-2024 | 28.0%  | 79.2%  | -2.0%   | 0.6   | 155.2  |
| 2023-2025 | 84.0%  | 79.2%  | 16.0%   | 0.5   | 245.9  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly, including negative values in the 2018-2020 period. The most recent period (2023-2025) shows strong growth.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial potential losses during downturns.
*   **Alpha:**  The Alpha is primarily negative, indicating underperformance relative to its risk-adjusted benchmark, except for the most recent period.
*   **Beta:** Beta values range from 0.5 to 1.2. A Beta of 1.0 suggests volatility in line with the market. A Beta greater than 1 (e.g., 1.2) indicates higher volatility than the market, and a Beta less than 1 (e.g., 0.5) suggests lower volatility.
*   **Cap:** Market Cap has generally increased over time, with significant growth in the most recent period.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 183.40
*   **Previous Close:** 184.01
*   **Change:** -0.33
*   **5-day SMA:** 184.68
*   **20-day SMA:** 178.97
*   **60-day SMA:** 174.14

**Analysis:** The stock price is currently slightly down from its previous close. The 5-day SMA is above the 20-day and 60-day SMAs, which in turn is above the 60-day SMA. This *could* indicate a short-term upward trend, but it's not definitive.

**3) Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended)
*   **RSI:** 67.74 (Approaching overbought territory.)
*   **PPO:** 0.19 (Positive, indicating short-term price momentum.)
*   **Hybrid Signal:** Buy 100% (Very Safe - MRI: 0.90)
*   **Recent Divergence Change:** Negative (단기하락, Short-term decline)
*   **Expected Return:** 0.0%

**Analysis:** The MRI suggests a Medium Investment recommendation, indicating moderate risk. The RSI is nearing overbought territory (above 70), suggesting a potential pullback.  The PPO is positive, suggesting some upward momentum. However, the recent negative divergence change indicates short-term downward pressure. The expected return of 0.0% suggests analysts do not expect the stock to outperform the S&P 500 over a long-term horizon.

**4) Recent News & Significant Events**

*   **Mixed Headlines:** The news headlines present a mixed picture. Some articles highlight record highs and strong defense orders, while others discuss underperformance relative to the broader market and investor sentiment.
*   **Key Themes:** Defense orders, investor sentiment, and technical price levels are recurring themes.
*   **Important Links**
    *   https://news.google.com/rss/articles/CBMid0FVX3lxTFB6YkdUdjZIZGU0T1FPZnRpMUxDQ3U0eGhLVm9mdTFpTm54OGVIUkYyYVJaNV9lRmRsWFZBRnBIQkl4REt5c0VxV01fMTgzcjcyc2NuakNvRklYNzFJcjlMVEVfbllla0dQb0ltb29HNFZjbVIxNFJz?oc=5
    *   https://news.google.com/rss/articles/CBMimAFBVV95cUxNV2FTNFktNDl6WTJfcC0xMGFtZTc3ckJ0eENoRXpLbkFDcnNNYXFmVkZBRmxNNmxJM0dnZTd0Zi1nUnVpSlFoZ3VMcGdqbUNHeHJRRUpXNG1QalFmdzZXSmpOUkZ2RXV0MzZOQ3JFM1d3ekNvaDdSQlpUYkVsWUhvS0RvNGV0aTdrbFBGNzRHU2hpb0hKRnF2VQ?oc=5
    *   https://news.google.com/rss/articles/CBMikgFBVV95cUxPdEZxVHo0cjI0anBuZld3akJZNWRyeERiUEV1aDB4cVdKaF9lVm5zajIwSHdhREVPNHJXOHNkeHNrdDhJZlJQd2lTX0pzSjJ0MDQ3M2FFbTVWY3JMZFJLdHBWbURvRVVaWVpFVmp6NnRXMmxtb1pYV1ZOQzBCTy1KTTJTOXRkMlNwdkpvM21Dbjlkdw?oc=5
    *   https://news.google.com/rss/articles/CBMipAFBVV95cUxQYVlwMHBUM2ZnZDVidExheDVTUzNSbXRvM080cURQWXAxcWVUdC1fc3YxWHJJdzJPeHhtcllVQk9ZSVlNZHM4STZ6R1VHaVQxSEt3N1BhSVl2a0xRS2hpbXVtSlNEOG9jOVpzYVJlR0xCblhSOEMzWE9hT01kN3o2dE9yYUdKTklGRlkwd29RYTc5THRzbDFvZ3o0YThPLVFIc0hyMg?oc=5
    *   https://news.google.com/rss/articles/CBMilAFBVV95cUxQSUpwQm54Q1U3Q2M2V2tSbkxRVFVyaWpwcEh0RUMweUN1NjB2Zm9tdXU0T3RUeFB0bDE0M2x0YWU5T1hRNXRJeVYwVkNRMjdabGRxWm81VVlMR1ljc3E4aGJGUnd0aGtUU0Zlc1lBa2lLVTFqS2Z6ZTROZFRsMVRNZzJUV3c5UUJIS1Y4S0RVSl9XQl9T?oc=5
    *   https://news.google.com/rss/articles/CBMikwFBVV95cUxQN0pVeVlJYlN3RTczZ2M1X3kzc1N6V2ZJTFY2OENMUDcxaV9PRTFRbWdrLUlHYkVpbUFtWGd0ZU4yeUNHSm1aVndmZ24wRGJvR1FMZ2FGbTA2VnpaVVZDSlJGcm5LbjYxQmZ5ZHlleW5ROWhOcjA0WDVKUnFyYlJOZWs2Ym5fX3RYVTZ3YlB2Y190akU?oc=5

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~1.86 on a 1-5 scale)
*   **Target Price (Avg/High/Low):** $195.95 / $219.00 / $150.00

**Analysis:** The analyst consensus is a "Buy" with a mean rating suggesting a generally positive outlook.  The average target price suggests potential upside from the current price.

**5) Recent Earnings Analysis**

| 날짜         | EPS  | 매출        |
|-------------|------|-------------|
| 2025-10-21 | 1.43 | 22.48 B$    |
| 2025-07-22 | 1.24 | 21.58 B$    |
| 2025-04-22 | 1.15 | 20.31 B$    |
| 2024-10-22 | 1.1  | 20.09 B$    |
| 2025-10-21 | 1.1  | 20.09 B$    |

**Analysis:** Both EPS (Earnings Per Share) and Revenue show a generally increasing trend over the reported quarters, indicating positive growth in profitability and sales. There appears to be a duplicate entry for 2025-10-21, which should be investigated for accuracy.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $22.48B   | 20.38%        |
| 2025-06-30   | $21.58B   | 20.28%        |
| 2025-03-31   | $20.31B   | 20.27%        |
| 2024-12-31   | $21.62B   | 19.59%        |
| 2024-09-30   | $20.09B   | 20.08%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $64.51B   | 2.97%  |
| 2025-06-30   | $62.40B   | 2.66%  |
| 2025-03-31   | $61.52B   | 2.50%  |
| 2024-12-31   | $60.16B   | 2.46%  |
| 2024-09-30   | $61.11B   | 2.41%  |

**Analysis:**

*   **Revenue:** Revenue is generally increasing, indicating sales growth.
*   **Profit Margin:** The profit margin is relatively stable around 20%, suggesting consistent profitability.
*   **Equity:** Equity is steadily increasing, reflecting the company's growing net worth.
*   **ROE (Return on Equity):** ROE is also increasing, indicating improved efficiency in generating profit from shareholder equity.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** RTX has significantly underperformed the S&P 500 in recent years.
*   **Growth Potential:** Recent earnings, revenue, and equity growth suggest positive momentum, and record backlogs are bullish, however, the high MDD from Alpha, Beta Analysis should be considered to mitigate the risk.
*   **Mixed Signals:** Technical indicators and news headlines present mixed signals, requiring careful interpretation. The RSI is nearing overbought levels, but analyst consensus is positive.
*   **Analyst Optimism:** Analysts generally have a positive outlook on RTX, with a "Buy" consensus and a target price suggesting upside potential.
*   **MRI Indication:** Current MRI is showing a "Medium Investment Recommended" signal.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.